查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1600610

临床试验用品市场：按阶段、类型、产品、治疗领域和最终用户 - 2025-2030 年全球预测

Clinical Trial Supplies Market by Phase (Phase I, Phase II, Phase III), Type (Biologic Drugs, Medical Devices, Small-Molecules), Product, Therapeutic Area, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年临床试验耗材市场规模为33.5亿美元，预计2024年将达36.4亿美元，复合年增长率为8.43%，预计2030年将达59.2亿美元。

临床试验用品市场包括进行临床试验所需的用品的製造、包装、标籤和分销，例如药品、医疗设备和其他与试验相关的材料。对这些物资的主要需求是促进对新疗法的严格测试，以确保其在到达患者手中之前的安全性和有效性。应用范围横跨製药、生技、医疗设备等生命科学领域，目标使用者为大型製药公司、科研院所、学术机构等。推动市场成长的关键因素包括慢性病的增加、生物技术的进步以及强劲的研发投资推动的临床试验的增加。此外，临床试验的全球化需要高效率的供应链策略，进一步推动市场扩张。最近的趋势，包括因 COVID-19 大流行而导致的技术整合以及临床试验的分散化和虚拟化，提供了潜在的商机。公司可以透过投资创新的数位工具来利用这些工具，例如用于透明度的区块链和用于物流优化的人工智慧。然而，严格的监管要求、高成本和供应链复杂性等挑战限制了成长。解决这些问题需要策略重点关注监管合规性和成本效率。低温运输物流、适应性试验设计和个人化医疗的创新可以进一步加速成长。为此，公司必须寻求先进的追踪系统和强大的云端基础的解决方案，以提高供应的安全性。市场的特点是竞争激烈、技术进步迅速，需要敏捷性和持续创新。整体而言，寻求发展的公司不仅必须透过全面的合规策略和先进的物流框架来应对这些挑战，还必须采用保证效率和可靠性的新技术。我们对这些领域的关注使我们能够满足临床试验不断变化的需求，并在保持竞争力的同时利用商业机会。

主要市场统计
基准年[2023] 33.5亿美元
预测年份 [2024] 36.4亿美元
预测年份 [2030] 59.2亿美元
复合年增长率（%） 8.43%

市场动态：揭示快速发展的临床试验用品市场的关键市场洞察

供需的动态交互作用正在改变临床试验用品市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 全球感染疾病和慢性病盛行率增加
    • 製药和生物製药产业研发支出增加
  • 市场限制因素
    • 临床试验耗材高成本
  • 市场机会
    • 重视药物开发并转向以病人为中心的临床试验
    • 多样化临床试验用品的持续进步
  • 市场挑战
    • 临床试验用品严格监管

波特的五力策略工具驾驭临床试验用品市场

波特的五力架构是了解临床试验用品市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解临床试验用品市场的外部影响

外部宏观环境因素在塑造临床试验用品市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解临床试验用品市场的竞争状况

临床试验用品市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵临床试验用品市场供应商的绩效评估

FPNV定位矩阵是评估临床试验用品市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。四个象限清楚且准确地划分供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键重点领域的全面市场分析：

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的大量资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地感染疾病和慢性病的盛行率正在增加。
      • 加大製药和生物製药产业的研发力度
    • 抑制因素
      • 临床试验耗材成本高
    • 机会
      • 重视药物开发并转向以病人为中心的临床试验
      • 多样化临床试验用品的持续进步
    • 任务
      • 临床试验用品严格监管
  • 市场区隔分析
    • 阶段：为了做出有关临床试验的最佳决策，对临床试验用品的需求逐阶段增加。
    • 类型：慢性病治疗方法突破，生物药需求快速成长
    • 产品：辅助药物是临床试验的关键组成部分，因为它们对于确保研究的安全性和整体效率至关重要。
    • 治疗领域：全球感染疾病负担增加，临床试验用品需求增加
    • 最终用户：研发活动外包的增加增加了 CRO 中临床试验用品的使用。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 临床试验用品市场分阶段状况

  • 第一阶段
  • 第二阶段
  • 第三阶段
  • 第四阶段

第七章 临床试验用品市场：依类型

  • 生物製药
  • 医疗设备
  • 小分子

第八章临床试验用品市场：副产品

  • 补充药物
  • 互动式响应技术（IRT）解决方案
  • 实验室用品
    • 离心机
    • 显微镜
    • 移液器
    • 试剂
  • 医疗设备和诊断
  • 药局用品
    • 生物危害袋
    • 复合无菌隔离器
    • 消毒器
  • 研究资料
  • 安全设备

第九章依治疗领域分類的临床试验用品市场

  • 心臟病学
  • 遗传疾病
  • 免疫学
  • 感染疾病
  • 代谢紊乱
  • 神经病学
  • 肿瘤学

第十章临床试验用品市场：依最终使用者分类

  • 合约调查机构
  • 製药和生物技术公司

第十一章 北美和南美临床试验用品市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太临床试验用品市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东、非洲临床试验用品市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 讯号：英国临床研究提供商 Ergomed 将以 8.88 亿美元收购
    • 赛默飞世尔科技推出全新智慧冰箱系列
    • Loftware 和 Tenthpin 合作开发临床供应标籤
    • Sitero 收购 Clario 的 eClinical 技术套件以增强临床试验执行
    • Replimune 和 Insight 签署临床试验合作和供应协议，以评估 RP1 和 INCB99280 在皮肤鳞状细胞癌患者中的应用
    • BD 推出新型机器人系统以实现临床流式细胞技术自动化
    • Lonza 收购 Synafix 以加强抗体药物复合体产品
    • IDEAYA 扩大了与辉瑞的临床试验合作和供应协议，以支持一项评估 Darovasertib 和 Crizotinib 组合用于转移性葡萄膜黑色素瘤一线治疗的註册试验。
    • Plus Therapeutics 扩大与 Piramal Pharma Solutions 的合作关係，以满足正在进行和计划的临床试验中对临床实验药物日益增长的需求
    • 西门子 Healthineers 在索兹开设实验设备研发中心
    • Experic完成1,400万美元B轮资金筹措
    • Medline 额外投资 5 亿美元用于医疗用品库存，以增强产品可用性

公司名单

  • Johnson & Johnson Services, Inc.
  • Bruker Corporation
  • Cardinal Health, Inc.
  • Rubicon Research Pvt. Ltd.
  • Sharp Services, LLC
  • Emsere BV by Medicapital Holdco BV
  • Medline Industries, LP
  • Thermo Fisher Scientific Inc.
  • Novo Nordisk A/S
  • Evident Corporation by Olympus Corporation
  • KLIFO A/S
  • Merck KGaA
  • Almac Group Limited
  • Woodley Equipment Company Ltd.
  • Lonza Group Ltd.
  • Pfizer Inc.
  • Leica Microsystems GmbH by Danaher Corporation
  • Myonex, LLC
  • Becton, Dickinson and Company
  • Stryker Corporation
  • Promega Corporation
  • Nuvisan GmbH
  • Incyte Corporation
  • 3M Company
  • Recipharm AB
  • Charles River Laboratories, Inc.
  • Siemens Healthcare GmbH
  • IQVIA Inc.
  • Parexel International Corporation
  • F. Hoffmann-La Roche Ltd.
  • Bayer AG
  • HORIBA, Ltd.
  • ICON PLC
  • Bio-Rad Laboratories, Inc.
  • COREX LOGISTICS LIMITED
  • Perceptive Informatics LLC and its affiliates, d/b/a Calyx
  • Immudex ApS
  • Eppendorf SE
  • Abbott Laboratories
  • PerkinElmer Inc. by Revvity, Inc.
  • Fujifilm Group
  • Hitachi, Ltd.
  • Hipro Biotechnology Co., Ltd.
  • Labnet International
  • Baxter International, Inc.
  • B. Braun SE
  • llumina, Inc.
  • Sekisui Diagnostics Group
  • Smith & Nephew PLC
Product Code: MRR-E0619F076721

The Clinical Trial Supplies Market was valued at USD 3.35 billion in 2023, expected to reach USD 3.64 billion in 2024, and is projected to grow at a CAGR of 8.43%, to USD 5.92 billion by 2030.

The clinical trial supplies market encompasses the manufacturing, packaging, labeling, and distribution of supplies needed to conduct clinical trials, including drugs, medical devices, and other study-related materials. The primary necessity of these supplies lies in their role in facilitating rigorous testing to ensure safety and efficacy before new treatments reach patients. The application scope extends across pharmaceuticals, biotechnology, medical devices, and other life sciences sectors, targeting end-users such as pharmaceutical giants, research organizations, and academic institutions. Key factors driving market growth include increasing clinical trials propelled by rising chronic diseases, advancing biotechnology, and robust R&D investments. Moreover, the globalization of clinical trials necessitates efficient supply chain strategies, further propelling market expansion. Recent trends involving decentralized and virtual trials due to technological integration and the COVID-19 pandemic offer potential opportunities. Businesses can capitalize on these by investing in innovative digital tools, such as blockchain for transparency or AI for logistics optimization. However, challenges like stringent regulatory requirements, high costs, and supply chain complexities pose growth constraints. Navigating these demands a strategic focus on regulatory compliance and cost efficiency. Innovations in cold chain logistics, adaptive trial designs, and personalized medicine can further spurn growth. To do so, companies should explore advanced tracking systems or robust cloud-based solutions to enhance supply security. The market is characterized by high competition and rapid technological advancements, necessitating agility and continual innovation. Overall, businesses aspiring for growth need not only to address these challenges with comprehensive compliance strategies and advanced logistical frameworks but also to embrace emerging technologies that promise efficiency and reliability. Emphasizing these areas will position businesses to leverage opportunities, addressing the evolving needs of clinical trials while maintaining a competitive edge.

KEY MARKET STATISTICS
Base Year [2023] USD 3.35 billion
Estimated Year [2024] USD 3.64 billion
Forecast Year [2030] USD 5.92 billion
CAGR (%) 8.43%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Clinical Trial Supplies Market

The Clinical Trial Supplies Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of infectious and chronic diseases worldwide
    • Rising research and development expenditure by pharmaceutical and biopharmaceutical industry
  • Market Restraints
    • High cost of clinical trial supplies
  • Market Opportunities
    • Emphasis on drug development and shift towards patient-centric clinical trials
    • Ongoing advancements in a diverse range of clinical trial supplies
  • Market Challenges
    • Stringent regulations for clinical trial supplies

Porter's Five Forces: A Strategic Tool for Navigating the Clinical Trial Supplies Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Clinical Trial Supplies Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Clinical Trial Supplies Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Clinical Trial Supplies Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Clinical Trial Supplies Market

A detailed market share analysis in the Clinical Trial Supplies Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Clinical Trial Supplies Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Clinical Trial Supplies Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Clinical Trial Supplies Market, highlighting leading vendors and their innovative profiles. These include Johnson & Johnson Services, Inc., Bruker Corporation, Cardinal Health, Inc., Rubicon Research Pvt. Ltd., Sharp Services, LLC, Emsere B.V by Medicapital Holdco B.V., Medline Industries, LP, Thermo Fisher Scientific Inc., Novo Nordisk A/S, Evident Corporation by Olympus Corporation, KLIFO A/S, Merck KGaA, Almac Group Limited, Woodley Equipment Company Ltd., Lonza Group Ltd., Pfizer Inc., Leica Microsystems GmbH by Danaher Corporation, Myonex, LLC, Becton, Dickinson and Company, Stryker Corporation, Promega Corporation, Nuvisan GmbH, Incyte Corporation, 3M Company, Recipharm AB, Charles River Laboratories, Inc., Siemens Healthcare GmbH, IQVIA Inc., Parexel International Corporation, F. Hoffmann-La Roche Ltd., Bayer AG, HORIBA, Ltd., ICON PLC, Bio-Rad Laboratories, Inc., COREX LOGISTICS LIMITED, Perceptive Informatics LLC and its affiliates, d/b/a Calyx, Immudex ApS, Eppendorf SE, Abbott Laboratories, PerkinElmer Inc. by Revvity, Inc., Fujifilm Group, Hitachi, Ltd., Hipro Biotechnology Co., Ltd., Labnet International, Baxter International, Inc., B. Braun SE, llumina, Inc., Sekisui Diagnostics Group, and Smith & Nephew PLC.

Market Segmentation & Coverage

This research report categorizes the Clinical Trial Supplies Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Phase, market is studied across Phase I, Phase II, Phase III, and Phase IV.
  • Based on Type, market is studied across Biologic Drugs, Medical Devices, and Small-Molecules.
  • Based on Product, market is studied across Auxiliary Medicinal Products, Interactive Response Technology (IRT) solutions, Lab Supplies, Medical Devices & Diagnostics, Pharmacy Supplies, Research Materials, and Safety Equipment. The Lab Supplies is further studied across Centrifuges, Microscopes, Pipettes, and Reagents. The Pharmacy Supplies is further studied across Biohazard Bags, Compounding Aseptic Isolators, and Sterilization Equipment.
  • Based on Therapeutic Area, market is studied across Cardiology, Genetic Diseases, Immunology, Infectious Diseases, Metabolic Disorders, Neurology, and Oncology.
  • Based on End User, market is studied across Contract Research Organisations and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of infectious and chronic diseases worldwide
      • 5.1.1.2. Rising research and development expenditure by pharmaceutical and biopharmaceutical industry
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of clinical trial supplies
    • 5.1.3. Opportunities
      • 5.1.3.1. Emphasis on drug development and shift towards patient-centric clinical trials
      • 5.1.3.2. Ongoing advancements in a diverse range of clinical trial supplies
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations for clinical trial supplies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Phase: Growing demand for clinical trial supplies for each phase for optimal decision-making regarding clinical trial
    • 5.2.2. Type: Surge in biologic drugs demand with breakthrough therapies for chronic ailments
    • 5.2.3. Product: Auxiliary medicinal products are vital elements of clinical trials, owing to their significance of assuring safety, and efficiency in the overall research operation
    • 5.2.4. Therapeutic Area: Rising burden of infectious diseases worldwide create a demand for clinical trial supplies
    • 5.2.5. End User: Growing use of clinical trial supplies in CROs due to rising outsourcing of R&D activities
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Clinical Trial Supplies Market, by Phase

  • 6.1. Introduction
  • 6.2. Phase I
  • 6.3. Phase II
  • 6.4. Phase III
  • 6.5. Phase IV

7. Clinical Trial Supplies Market, by Type

  • 7.1. Introduction
  • 7.2. Biologic Drugs
  • 7.3. Medical Devices
  • 7.4. Small-Molecules

8. Clinical Trial Supplies Market, by Product

  • 8.1. Introduction
  • 8.2. Auxiliary Medicinal Products
  • 8.3. Interactive Response Technology (IRT) solutions
  • 8.4. Lab Supplies
    • 8.4.1. Centrifuges
    • 8.4.2. Microscopes
    • 8.4.3. Pipettes
    • 8.4.4. Reagents
  • 8.5. Medical Devices & Diagnostics
  • 8.6. Pharmacy Supplies
    • 8.6.1. Biohazard Bags
    • 8.6.2. Compounding Aseptic Isolators
    • 8.6.3. Sterilization Equipment
  • 8.7. Research Materials
  • 8.8. Safety Equipment

9. Clinical Trial Supplies Market, by Therapeutic Area

  • 9.1. Introduction
  • 9.2. Cardiology
  • 9.3. Genetic Diseases
  • 9.4. Immunology
  • 9.5. Infectious Diseases
  • 9.6. Metabolic Disorders
  • 9.7. Neurology
  • 9.8. Oncology

10. Clinical Trial Supplies Market, by End User

  • 10.1. Introduction
  • 10.2. Contract Research Organisations
  • 10.3. Pharmaceutical & Biotechnology Companies

11. Americas Clinical Trial Supplies Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Clinical Trial Supplies Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Clinical Trial Supplies Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Signal: UK Clinical Research Provider Ergomed Bought Out in USD 888 Million Deal
    • 14.3.2. Thermo Fisher Scientific Launches New Smart Refrigerator Series
    • 14.3.3. Loftware and Tenthpin Collaborate on Clinical Supply Labeling
    • 14.3.4. Sitero Acquires Clario's eClinical Technology Suite to Enhance Clinical Trial Delivery
    • 14.3.5. Replimune and Incyte Enter into Clinical Trial Collaboration and Supply Agreement to Evaluate RP1 and INCB99280 in Patients with Cutaneous Squamous Cell Carcinoma
    • 14.3.6. BD Launches New Robotic System to Automate Clinical Flow Cytometry
    • 14.3.7. Lonza to Acquire Synaffix and Strengthen Antibody-Drug Conjugates Offering
    • 14.3.8. IDEAYA Expands Clinical Trial Collaboration and Supply Agreements with Pfizer to Support Registrational Trial Evaluating Darovasertib and Crizotinib Combination in First-Line Metastatic Uveal Melanoma
    • 14.3.9. Plus Therapeutics Expands Collaboration with Piramal Pharma Solutions to Meet Increase in Investigational Drug Demand for Ongoing and Planned Clinical Trials
    • 14.3.10. Siemens Healthineers Launch Laboratory Equipment R&D Centre in Swords
    • 14.3.11. Experic Closes USD 14 Million Series B Financing
    • 14.3.12. Medline Invests Additional USD 500M in Medical Supply Inventory to Boost Product Availability

Companies Mentioned

  • 1. Johnson & Johnson Services, Inc.
  • 2. Bruker Corporation
  • 3. Cardinal Health, Inc.
  • 4. Rubicon Research Pvt. Ltd.
  • 5. Sharp Services, LLC
  • 6. Emsere B.V by Medicapital Holdco B.V.
  • 7. Medline Industries, LP
  • 8. Thermo Fisher Scientific Inc.
  • 9. Novo Nordisk A/S
  • 10. Evident Corporation by Olympus Corporation
  • 11. KLIFO A/S
  • 12. Merck KGaA
  • 13. Almac Group Limited
  • 14. Woodley Equipment Company Ltd.
  • 15. Lonza Group Ltd.
  • 16. Pfizer Inc.
  • 17. Leica Microsystems GmbH by Danaher Corporation
  • 18. Myonex, LLC
  • 19. Becton, Dickinson and Company
  • 20. Stryker Corporation
  • 21. Promega Corporation
  • 22. Nuvisan GmbH
  • 23. Incyte Corporation
  • 24. 3M Company
  • 25. Recipharm AB
  • 26. Charles River Laboratories, Inc.
  • 27. Siemens Healthcare GmbH
  • 28. IQVIA Inc.
  • 29. Parexel International Corporation
  • 30. F. Hoffmann-La Roche Ltd.
  • 31. Bayer AG
  • 32. HORIBA, Ltd.
  • 33. ICON PLC
  • 34. Bio-Rad Laboratories, Inc.
  • 35. COREX LOGISTICS LIMITED
  • 36. Perceptive Informatics LLC and its affiliates, d/b/a Calyx
  • 37. Immudex ApS
  • 38. Eppendorf SE
  • 39. Abbott Laboratories
  • 40. PerkinElmer Inc. by Revvity, Inc.
  • 41. Fujifilm Group
  • 42. Hitachi, Ltd.
  • 43. Hipro Biotechnology Co., Ltd.
  • 44. Labnet International
  • 45. Baxter International, Inc.
  • 46. B. Braun SE
  • 47. llumina, Inc.
  • 48. Sekisui Diagnostics Group
  • 49. Smith & Nephew PLC

LIST OF FIGURES

  • FIGURE 1. CLINICAL TRIAL SUPPLIES MARKET RESEARCH PROCESS
  • FIGURE 2. CLINICAL TRIAL SUPPLIES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. CLINICAL TRIAL SUPPLIES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. CLINICAL TRIAL SUPPLIES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CLINICAL TRIAL SUPPLIES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CLINICAL TRIAL SUPPLIES MARKET DYNAMICS
  • TABLE 7. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE IV, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY SMALL-MOLECULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY AUXILIARY MEDICINAL PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INTERACTIVE RESPONSE TECHNOLOGY (IRT) SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MICROSCOPES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PIPETTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MEDICAL DEVICES & DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY BIOHAZARD BAGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COMPOUNDING ASEPTIC ISOLATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STERILIZATION EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY RESEARCH MATERIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY SAFETY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY GENETIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CONTRACT RESEARCH ORGANISATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 96. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 100. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 102. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 104. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 107. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 108. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 109. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 111. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 114. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 115. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 116. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 118. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 121. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 122. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 123. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 125. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 128. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 129. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 130. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 132. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 135. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 136. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 137. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 139. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 142. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 143. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 144. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 146. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 149. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 150. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 151. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 153. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 156. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 157. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 158. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 159. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 160. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 163. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 164. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 165. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 167. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 170. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 171. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 172. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. VIETNAM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 174. VIETNAM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. VIETNAM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. VIETNAM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 177. VIETNAM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 178. VIETNAM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 179. VIETNAM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 188. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 189. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 192. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 193. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 194. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 195. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 196. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 199. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 200. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 201. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 202. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 203. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 206. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 207. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 208. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 209. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 210. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 213. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 214. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 215. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 216. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 217. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 220. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 221. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 222. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 223. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 224. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 227. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 228. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 229. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 230. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 231. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 234. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 235. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 236. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 237. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 238. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 240. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 241. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 242. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 243. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 244. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 245. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 247. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 248. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 249. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 250. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 251. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 252. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 254. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 255. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 256. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 257. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 258. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 259. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 261. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 262. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 263. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 264. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 265. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 266. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 268. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 269. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 270. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 271. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 272. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 273. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 275. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 276. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 277. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 278. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 279. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 280. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 281. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 282. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 283. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 284. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 285. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 286. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 287. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 288. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 289. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 290. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 291. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 292. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 293. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 294. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 295. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 296. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 297. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 298. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 299. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 300. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 301. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 302. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 303. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 304. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 305. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 306. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 307. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 308. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 309. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 310. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 311. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 312. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 313. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 314. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 315. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 316. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 317. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 318. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 319. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 320. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 324. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 325. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 326. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 327. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 328. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 329. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 330. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 331. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 332. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2030 (USD MILLION)
  • TABLE 333. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 334. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 335. CLINICAL TRIAL SUPPLIES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 336. CLINICAL TRIAL SUPPLIES MARKET, FPNV POSITIONING MATRIX, 2023